Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2020

View Archived Issues

CanSino Biologics and PNI collaborate to develop COVID-19 RNA vaccine

First U.K. frontline healthcare workers enrolled in the largest COVID-19 interventional trial

Kleo and Celularity collaborate to develop allogeneic NK-cell combination therapies

Health Canada gives clearance for phase II study of favipiravir as prophylactic against COVID-19

Cervello Therapeutics patents ROCK inhibitors

Merck & Co. discloses muscarinic M4 receptor PAMs

China NMPA gives clearance for phase II study of TJ-107/HyLeukin-7 in GBM

GPX2 as novel biomarker and target in bladder cancer

Phase I data published for Zika purified inactivated virus vaccine

ViiV Healthcare presents new antivirals for HIV infection

Esteve Pharmaceuticals synthesizes new analgesic drugs

New RET inhibitors presented by Medshine Discovery

Post-translational antibody modification triggers allergies

ACE correlates with antipsychotic treatment resistance in psychosis

CD8+/gp350-CAR+-T cells show efficacy in Epstein-Barr virus infection model

SV2A synaptic marker not altered by antipsychotic treatment in rats

FDA approves Kynmobi sublingual film to treat "off" episodes in Parkinson's disease

Final data show phase II study of ATL-1102 in DMD meets primary endpoint

Navidea reports second interim analysis from phase IIb study of Tc99m tilmanocept imaging in RA

Phase III trial of entinostat in HR-positive, HER-negative breast cancer misses primary endpoint

Vaxart selects lead COVID-19 vaccine candidate

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...